Logo image of ALHRG.PA

HERIGE (ALHRG.PA) Stock Fundamental Analysis

EPA:ALHRG - Euronext Paris - Matif - FR0000066540 - Common Stock - Currency: EUR

22.85  -0.15 (-0.65%)

Fundamental Rating

5

Taking everything into account, ALHRG scores 5 out of 10 in our fundamental rating. ALHRG was compared to 16 industry peers in the Trading Companies & Distributors industry. While ALHRG belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ALHRG has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ALHRG was profitable.
ALHRG had a positive operating cash flow in the past year.
ALHRG had positive earnings in each of the past 5 years.
Each year in the past 5 years ALHRG had a positive operating cash flow.
ALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

1.2 Ratios

With an excellent Return On Assets value of 6.53%, ALHRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
The Return On Equity of ALHRG (14.82%) is better than 93.75% of its industry peers.
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROIC N/A
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ALHRG.PA Yearly ROA, ROE, ROICALHRG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

ALHRG has a better Profit Margin (3.41%) than 75.00% of its industry peers.
In the last couple of years the Profit Margin of ALHRG has grown nicely.
In the last couple of years the Operating Margin of ALHRG has grown nicely.
ALHRG has a Gross Margin of 43.42%. This is amongst the best in the industry. ALHRG outperforms 93.75% of its industry peers.
ALHRG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.41%
GM 43.42%
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
ALHRG.PA Yearly Profit, Operating, Gross MarginsALHRG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALHRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHRG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALHRG has less shares outstanding
Compared to 1 year ago, ALHRG has an improved debt to assets ratio.
ALHRG.PA Yearly Shares OutstandingALHRG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ALHRG.PA Yearly Total Debt VS Total AssetsALHRG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

ALHRG has an Altman-Z score of 3.13. This indicates that ALHRG is financially healthy and has little risk of bankruptcy at the moment.
ALHRG has a Altman-Z score of 3.13. This is in the better half of the industry: ALHRG outperforms 62.50% of its industry peers.
ALHRG has a debt to FCF ratio of 20.35. This is a negative value and a sign of low solvency as ALHRG would need 20.35 years to pay back of all of its debts.
ALHRG has a Debt to FCF ratio of 20.35. This is in the better half of the industry: ALHRG outperforms 62.50% of its industry peers.
ALHRG has a Debt/Equity ratio of 0.70. This is a neutral value indicating ALHRG is somewhat dependend on debt financing.
ALHRG's Debt to Equity ratio of 0.70 is on the low side compared to the rest of the industry. ALHRG is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Altman-Z 3.13
ROIC/WACCN/A
WACC5.25%
ALHRG.PA Yearly LT Debt VS Equity VS FCFALHRG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.39 indicates that ALHRG has no problem at all paying its short term obligations.
ALHRG has a Current ratio of 2.39. This is in the better half of the industry: ALHRG outperforms 75.00% of its industry peers.
ALHRG has a Quick Ratio of 1.91. This is a normal value and indicates that ALHRG is financially healthy and should not expect problems in meeting its short term obligations.
ALHRG has a Quick ratio of 1.91. This is in the better half of the industry: ALHRG outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.91
ALHRG.PA Yearly Current Assets VS Current LiabilitesALHRG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.12% over the past year.
Measured over the past years, ALHRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.38% on average per year.
The Revenue for ALHRG has decreased by -14.27% in the past year. This is quite bad
Measured over the past years, ALHRG shows a small growth in Revenue. The Revenue has been growing by 6.67% on average per year.
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%

3.2 Future

ALHRG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -21.24% yearly.
Based on estimates for the next years, ALHRG will show a very negative growth in Revenue. The Revenue will decrease by -16.91% on average per year.
EPS Next Y2.21%
EPS Next 2Y-48.32%
EPS Next 3Y-21.24%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHRG.PA Yearly Revenue VS EstimatesALHRG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 200M 400M 600M 800M
ALHRG.PA Yearly EPS VS EstimatesALHRG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.70 indicates a rather cheap valuation of ALHRG.
ALHRG's Price/Earnings ratio is rather cheap when compared to the industry. ALHRG is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.22. ALHRG is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for ALHRG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 2.7
Fwd PE N/A
ALHRG.PA Price Earnings VS Forward Price EarningsALHRG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHRG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHRG indicates a somewhat cheap valuation: ALHRG is cheaper than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.07
EV/EBITDA 2.43
ALHRG.PA Per share dataALHRG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

ALHRG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALHRG may justify a higher PE ratio.
A cheap valuation may be justified as ALHRG's earnings are expected to decrease with -21.24% in the coming years.
PEG (NY)1.22
PEG (5Y)0.06
EPS Next 2Y-48.32%
EPS Next 3Y-21.24%

0

5. Dividend

5.1 Amount

ALHRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERIGE

EPA:ALHRG (5/2/2025, 7:00:00 PM)

22.85

-0.15 (-0.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)05-12 2025-05-12
Inst Owners1.53%
Inst Owner ChangeN/A
Ins Owners17.74%
Ins Owner ChangeN/A
Market Cap68.32M
Analysts84.44
Price Target31.62 (38.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.78
Dividend Growth(5Y)29.19%
DP22.12%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.82%
PT rev (3m)-8.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 2.7
Fwd PE N/A
P/S 0.1
P/FCF 12.07
P/OCF 2.59
P/B 0.42
P/tB 0.59
EV/EBITDA 2.43
EPS(TTM)8.45
EY36.98%
EPS(NY)-1.37
Fwd EYN/A
FCF(TTM)1.89
FCFY8.29%
OCF(TTM)8.81
OCFY38.56%
SpS239.42
BVpS55.05
TBVpS38.8
PEG (NY)1.22
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.41%
GM 43.42%
FCFM 0.79%
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.95%
ROCE(5y)7.85%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
F-Score8
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Debt/EBITDA 3.78
Cap/Depr 65.84%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion 86.44%
Profit Quality 23.2%
Current Ratio 2.39
Quick Ratio 1.91
Altman-Z 3.13
F-Score8
WACC5.25%
ROIC/WACCN/A
Cap/Depr(3y)130.39%
Cap/Depr(5y)150%
Cap/Sales(3y)3.56%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
EPS Next Y2.21%
EPS Next 2Y-48.32%
EPS Next 3Y-21.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A
EBIT growth 1Y-103.11%
EBIT growth 3Y11.4%
EBIT growth 5Y20.51%
EBIT Next Year80%
EBIT Next 3Y8.97%
EBIT Next 5YN/A
FCF growth 1Y128.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y631.63%
OCF growth 3Y-23.55%
OCF growth 5Y5.66%